Filing Details

Accession Number:
0000905148-21-000432
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-05 13:00:00
Reporting Period:
2021-05-03
Accepted Time:
2021-05-05 18:19:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1484612 Outset Medical Inc. OM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1304125 Leslie Trigg 3052 Orchard Drive
San Jose CA 95134
President & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-03 20,000 $1.11 270,658 No 4 M Direct
Common Stock Disposition 2021-05-03 15,762 $57.83 254,896 No 4 S Direct
Common Stock Disposition 2021-05-03 3,592 $58.73 251,304 No 4 S Direct
Common Stock Disposition 2021-05-03 646 $59.82 250,658 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-05-03 20,000 $0.00 20,000 $1.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
33,081 2025-03-13 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 8,770 Indirect Held by Trigg Family Trust U/A DTD 01/01/2002
Footnotes
  1. These shares of common stock of the Issuer ("Shares") are held directly by The Trigg Family Trust U/A DTD 01/01/2002, for which the reporting person and her spouse serve as trustees.
  2. The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $57.34 to $58.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
  3. The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $58.404 to $59.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
  4. The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $59.77 to $60.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4).
  5. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020.
  6. This option vested in 48 equal monthly installments beginning on December 17, 2014.